CITIUS ONCOLOGY, INC. Annual Return On Equity in % from 2022 to 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Citius Oncology, Inc. quarterly/annual Return On Equity history and growth rate from 2022 to 2024.
  • Citius Oncology, Inc. Return On Equity for the quarter ending December 31, 2024 was -113 %, a 309% decline year-over-year.
  • Citius Oncology, Inc. annual Return On Equity for 2024 was -133 %, a 768% decline from 2023.
  • Citius Oncology, Inc. annual Return On Equity for 2023 was 20 %, a 380% increase from 2022.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
* An asterisk sign (*) next to the value indicates that the value is likely invalid.